BackClover Health Investments Overview

Clover Health Investments Other Current Liabilities

Track Clover Health Investments's other current liabilities ($290M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$287.92M
42.57% YoYΔ $85.97M vs prior year quarter

Peer trimmed avg / median

Loading

Clover Health Investments Other Current Liabilities History

Loading

Clover Health Investments vs. peers: Other Current Liabilities Comparison

Loading

Clover Health Investments Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Clover Health Investments (CLOV) FAQ

Clover Health Investments's other current liabilities stands at $290M as of June 2026. That compares with $200M in the prior-year period — up 42.6% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Clover Health Investments reported $290M in other current liabilities versus $200M a year earlier — a 42.6% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $200M in the prior-year period — up 42.6% year over year. Sustained growth in other current liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Clover Health Investments's other current liabilities evolved across reporting periods, while the comparison chart places CLOV next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Finance, other current liabilities is commonly used to spot outliers. Clover Health Investments's reading of $290M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.